This trial is active, not recruiting.

Condition lung cancer survivors
Treatment questionnaires or telephone interview
Sponsor Memorial Sloan Kettering Cancer Center
Collaborator Fox Chase Cancer Center
Start date June 2005
End date June 2017
Trial size 193 participants
Trial identifier NCT00586937, 05-057


The purpose of this study is to find out about the quality of life of individuals who have been diagnosed and treated for lung cancer (lung cancer survivors). By quality of life, we mean how you are feeling about different aspects of your life, including your physical health, your emotional health, and your ability to carry out daily activities. We are interested in people's opinions about their quality of life, as well as the factors that affect their quality of life. Learning about quality of life will help us to develop new services for lung cancer survivors.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model case-only
Time perspective prospective
Lung Cancer Survivors
questionnaires or telephone interview
In the first phase, a random sample of lung cancer survivors will complete a comprehensive telephone interview or questionnaire by self-report focusing on assessment of quality of life and related covariates. We estimate the total time for completion of the survey by telephone interview or self-report to be 45-60 minutes. second phase of the study, a subset of telephone survey participants will take part in a focus group discussion that will explore their perceptions of barriers for delivery of post-treatment medical and psychosocial follow-up care.

Primary Outcomes

To describe the health-related quality of life (HQOL) of lung cancer survivors and compare their HQOL with age- and gender-appropriate, population-based normative data.
time frame: 2 years

Secondary Outcomes

To describe and identify covariates of HQOL in lung cancer survivors.
time frame: 2 years

Eligibility Criteria

Male or female participants of any age.

Inclusion Criteria: - Diagnosis of primary Stage IA or IB NSCLC; - Underwent surgical resection for NSCLC at MSKCC; - From 1 to 5 years and 11 months post-treatment for NSCLC prior to study recruitment; - No evidence of disease (NED) at the time of recruitment; - Can be reached by telephone; - Able to provide informed consent. Exclusion Criteria: - Undergoing active antineoplastic treatment; - Major psychopathology or cognitive impairment likely in the judgment of the investigator to interfere with participation and compliance with the protocol.

Additional Information

Official title Quality of Life in Lung Cancer Survivors
Principal investigator Jamie Ostroff, PhD
Trial information was received from ClinicalTrials.gov and was last updated in July 2016.
Information provided to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center.